Management of the Patient at High Risk for Breast Cancer

<p>CHAPTER 1:  IDENTIFYING WOMEN AT HIGH RISK OF BREAST CANCER: UNDERSTANDING THE RISK MODELS</p><p> </p><p>Scott M. Weissman, MS, CGC</p><p> </p><p>CHAPTER 2: GENETIC AND GENOMIC FACTORS IN BREAST CANCER</p><p></p><p>Lee P. Shulman MD</p><p></p><p>CHAPTER 3: BRCA MUTATION</p><p> </p><p>Ashley N. Hardy, MD, Elizabeth Tarasewicz, BS, Jacqueline Jeruss, MD, PhD</p><p> </p><p>CHAPTER 4: HIGH RISK BREAST LESIONS AND PATHOLOGIC EVALUATION</p><p> </p><p>Thomas Lawton, MD</p><p> </p><p>CHAPTER 5: MANAGEMENT OF HIGH RISK LESIONS</p><p> </p><p>Christine M. Gresik, MD, Seema A Khan, MD</p><p> </p><p>CHAPTER 6: RADIOLOGIC IMAGING FOR THE HIGH RISK PATIENT</p><p> </p><p>Erin Neuschler, MD, Paula Grabler, MD</p><p> </p><p>CHAPTER 7: RISK REDUCTION STRATEGIES: MEDICAL ONCOLOGY</p><p> </p><p>Virginia Kaklamani, MD, DSc</p><p> </p><p>CHAPTER 8: RISK REDUCTION STRATEGIES: SURGICAL PERSPECTIVE</p><p> </p><p>Lisa Spiguel, MD, Nora Hansen, MD</p><p> </p><p>CHAPTER 9: OPTIONS AND ADVANCES IN BREAST RECONSTRUCTION</p><p> </p><p>John Y Kim, MD, Vinay Rawlani, MD, Jennifer E. Cheesborough, MD</p><p> </p><p>CHAPTER 10: MANAGEMENT OF CONCOMITANT CANCER RISK</p><p> </p><p>Megan E. Miller, MD, Sarah Neilsen, MS, CGC, Swati A. Kulkarni, MD</p><p> </p><p>CHAPTER 11: PSYCHOLOGICAL IMPLICATIONS OF TESTING POSITIVE FOR THE BRCA GENE</p><p> </p><p>Timothy Pearman, PhD</p><p> </p><p>CHAPTER 12: THE HIGH TECH HIGH RISK CLINIC</p><p> </p><p>Brian Drohan, PhD, Constance Roche, ANP-BC, ONC, APNG, Kevin S. Hughes, MD, FACS</p><p> </p><p>CHAPTER 13: CURRENT AND FUTURE DIRECTION IN BASIC AND TRANSLATIONAL RESEARCH </p><p> </p><p>Susan Love, MD</p>